InverseOne

Home

HLB

028300, KOSDAQ, Healthcare

₩32,000▲ ₩99+0.31%
Prev. close
₩31,901
Volume
276.7K
Market cap
₩4.3T
  • Near 52-week low
  • -54% from high
  • Low-volatility blue chip

Stock and sector context

Healthcareinflow
Sector comparison
HLB changed +0.31%. The 13 covered Healthcare stocks in Korean averaged +0.59%, with estimated sector flow of inflow.
Variables to watch
Drug approvals and trial resultsDrug pricing policyUS interest ratesUSD/KRW
Risks to check
  • -54% below the high, the downtrend may continue
  • Clinical trial failure
  • Drug pricing pressure

This compares price changes among covered stocks in the same market. It does not establish why prices moved. Variables and risks are sector reference lists.

Why a candidate

Exp 70/100

The 0–100 score combines the 52-week range, valuation metrics, price changes and volume. It is not a probability of rising or a forecast return.

Gap to 52w high +116%OversoldInflow

Today's read

HLB scores 70 out of 100 on today's InverseOne expectation ranking, 10 of 60 in the Korean large-cap universe. There is 116% of room left to its 52-week high. Today's move of +0.31% came with money flowing in, alongside the Healthcare sector. Scores are estimates built from price and volume, a starting point for research rather than a trading signal.

Data basis: 2026-09-17 close, 09-19 00:18 KST updated, For reference only, not advice

Lending balance

Little change

13,149,844 sh

KRW 0.42T

1D -0.12%5D +1.17%

New 372,456 sh, Returned 387,623 sh

Shares borrowed through securities lending that have not yet been returned. Borrowed shares are often sold afterwards, so the balance is used as a reference for pending sell pressure.

As of 2026-09-17, FSC stock lending data

Talk about this stock

New thread

Today's talking points

  • It sits low in its 52-week range (17).
  • It is 116% below its 52-week high.

Three months out, which way do you see it?

Nobody has answered yet. Sign in to be the first.

These are answers picked by members, not investment advice.

Fund-flow signal

Unlock this stock's fund-flow signal and multi-day trend

  • Estimated net flow and signal grade, based on price and volume
  • Money-flow rank within the market and sector
  • 7-day flow trend and streak
  • Overlapping combo readings
Today's data for this stock is ready

Name, deep signal, 7-day trend, trade

1 credit. Reopening the same stock costs nothing.

Market data

52-week range
₩24,150 ~ ₩69,200
52-week position17/100
₩24,150₩69,200
Upside to 52w high+116.3%

AI zone read

Related news

From the headlinesShareholder dilution

Same-sector stocks

Sam Chun Dang Pharm000250, Healthcare+4.74%Celltrion068270, Healthcare+1.75%CLASSYS214150, Healthcare-1.72%ST Pharm237690, Healthcare+1.66%Lunit328130, Healthcare+1.10%Celltrion Pharm068760, Healthcare+1.03%Samsung Biologics207940, Healthcare-0.92%LigaChem Biosciences141080, Healthcare+0.73%

These figures are reference estimates built from price and volume: a starting point for narrowing down ideas, not a buy or sell signal.